Insider Transactions in Q2 2021 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 10
2021
|
Ian Clements Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
981
+9.98%
|
$13,734
$14.62 P/Share
|
|
May 10
2021
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,259
+1.61%
|
$17,626
$14.62 P/Share
|
|
May 10
2021
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,453
+33.97%
|
$20,342
$14.62 P/Share
|
|
May 10
2021
|
Peter Radovich PRESIDENT AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,006
+18.23%
|
$14,084
$14.62 P/Share
|
|
May 10
2021
|
Edwin Jonathan Tucker Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,483
+3.66%
|
$20,762
$14.62 P/Share
|
|
May 10
2021
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
699
+19.39%
|
$9,786
$14.62 P/Share
|